(Q33306763)

25 July 2017

title

AICAR inhibits proliferation and induced S-phase arrest, and promotes apoptosis in CaSki cells (English)

1 reference

25 July 2017

Tong-ju Guan

1 reference

25 July 2017

Feng-jin Qin

1 reference

25 July 2017

Jian-hai Du

1 reference

25 July 2017

Li Geng

1 reference

25 July 2017

You-yi Zhang

1 reference

25 July 2017

Min Li

1 reference

25 July 2017

publication date

1 December 2007

1 reference

Acta Pharmacologica Sinica

25 July 2017

published in

1 reference

25 July 2017

1 reference

25 July 2017

1 reference

25 July 2017

page(s)

1984-1990

1 reference

Inhibition of growth of cervical cancer cells using a dominant negative estrogen receptor gene

25 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2007.00675.X

p53 regulates ERK activation in carboplatin induced apoptosis in cervical carcinoma: a novel target of p53 in apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2007.00675.X

Phosphatidylinositol 3-kinase inhibition by LY294002 radiosensitizes human cervical cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2007.00675.X

Inhibition of the mammalian target of rapamycin (mTOR) by rapamycin increases chemosensitivity of CaSki cells to paclitaxel

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2007.00675.X

AMPK, the metabolic syndrome and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2007.00675.X

5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside inhibits cancer cell proliferation in vitro and in vivo via AMP-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2007.00675.X

AMP-activated protein kinase activators can inhibit the growth of prostate cancer cells by multiple mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2007.00675.X

Interaction between the AMP-activated protein kinase and mTOR signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2007.00675.X

Phosphoinositide 3-kinase/Akt signaling pathway and its therapeutical implications for human acute myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2007.00675.X

Molecular profiling of cervical cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2007.00675.X

Interference with energy metabolism by 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside induces HPV suppression in cervical carcinoma cells and apoptosis in the absence of LKB1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2007.00675.X

AMP-activated protein kinase inhibits angiotensin II-stimulated vascular smooth muscle cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2007.00675.X

Dysfunctional AMPK activity, signalling through mTOR and survival in response to energetic stress in LKB1-deficient lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2007.00675.X

ERK activation mediates cell cycle arrest and apoptosis after DNA damage independently of p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7254.2007.00675.X

10.1111/J.1745-7254.2007.00675.X

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

25 July 2017

1003480410

0 references

1 reference